ArticleClinicoEconomics and outcomes research : CEOR2019

Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspective.

Richard Macaulay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.